NASDAQ:DOCS Doximity (DOCS) Stock Price, News & Analysis $57.83 +2.65 (+4.80%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends About Doximity Stock (NASDAQ:DOCS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Doximity alerts:Sign Up Key Stats Today's Range$53.81▼$58.0850-Day Range$41.25▼$61.2552-Week Range$22.96▼$61.75Volume7.96 million shsAverage Volume1.78 million shsMarket Capitalization$10.80 billionP/E Ratio66.47Dividend YieldN/APrice Target$52.59Consensus RatingHold Company OverviewDoximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.Read More… Doximity Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks60th Percentile Overall ScoreDOCS MarketRank™: Doximity scored higher than 60% of companies evaluated by MarketBeat, and ranked 411th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.2 / 5Analyst RatingHold Consensus RatingDoximity has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 6 buy ratings, 13 hold ratings, and no sell ratings.Amount of Analyst CoverageDoximity has been the subject of 14 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Doximity's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth11.36% Earnings GrowthEarnings for Doximity are expected to grow by 11.36% in the coming year, from $0.88 to $0.98 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Doximity is 66.47, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 113.39.Price to Earnings Ratio vs. SectorThe P/E ratio of Doximity is 66.47, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 89.97.Price to Earnings Growth RatioDoximity has a PEG Ratio of 4.16. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioDoximity has a P/B Ratio of 11.97. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for DOCS. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldDoximity does not currently pay a dividend.Dividend GrowthDoximity does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for DOCS. News and Social Media3.3 / 5News Sentiment0.87 News SentimentDoximity has a news sentiment score of 0.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.60 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 13 news articles for Doximity this week, compared to 9 articles on an average week.Search InterestOnly 21 people have searched for DOCS on MarketBeat in the last 30 days. This is a decrease of -5% compared to the previous 30 days.MarketBeat Follows34 people have added Doximity to their MarketBeat watchlist in the last 30 days. This is an increase of 21% compared to the previous 30 days. Company Ownership3.3 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Doximity insiders have not sold or bought any company stock.Percentage Held by Insiders37.40% of the stock of Doximity is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions87.19% of the stock of Doximity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Doximity's insider trading history. Receive DOCS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Doximity and its competitors with MarketBeat's FREE daily newsletter. Email Address DOCS Stock News HeadlinesStephens & Co. Initiates Coverage of Doximity (DOCS) with Equal-Weight RecommendationDecember 21 at 4:55 AM | msn.comDoximity initiated with an Equal Weight at StephensDecember 20 at 11:50 PM | markets.businessinsider.comDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."December 21, 2024 | Banyan Hill Publishing (Ad)Why Did Doximity Inc. (DOCS) Jump Yesterday?December 20 at 11:50 PM | msn.comThis Health Care Software Firm Nears Buy Point After Whopping 101% Year-To-Date GainDecember 20 at 3:20 PM | investors.comDOXIMITY ALERT: Bragar Eagel & Squire, P.C. is Investigating Doximity, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmDecember 19 at 9:00 PM | globenewswire.comDoximity Report Confirms That Telemedicine Serves Key Role in Modern Health CareDecember 17, 2024 | finance.yahoo.comDoximity (DOCS) Management Regained Investors Trust Through Solid ExecutionDecember 10, 2024 | msn.comSee More Headlines DOCS Stock Analysis - Frequently Asked Questions How have DOCS shares performed this year? Doximity's stock was trading at $28.04 on January 1st, 2024. Since then, DOCS shares have increased by 106.2% and is now trading at $57.83. View the best growth stocks for 2024 here. How were Doximity's earnings last quarter? Doximity, Inc. (NASDAQ:DOCS) announced its quarterly earnings data on Tuesday, November, 9th. The company reported $0.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.06 by $0.13. The business had revenue of $79.35 million for the quarter, compared to analyst estimates of $73.60 million. Doximity had a net margin of 33.69% and a trailing twelve-month return on equity of 19.79%. When did Doximity IPO? Doximity (DOCS) raised $501 million in an IPO on Thursday, June 24th 2021. The company issued 23,300,000 shares at $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities served as the underwriters for the IPO and Piper Sandler, William Blair, Canaccord and Raymond James were co-managers. Who are Doximity's major shareholders? Doximity's top institutional shareholders include FMR LLC (3.68%), Baillie Gifford & Co. (2.89%), State Street Corp (1.99%) and ArrowMark Colorado Holdings LLC (1.91%). Insiders that own company stock include Anna Bryson, Paul W Jorgensen, Craig Overpeck, Watkin Phoebe L Yang, Timothy S Cabral, Kira Scherer Wampler and Gilbert H Kliman. View institutional ownership trends. How do I buy shares of Doximity? Shares of DOCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Doximity own? Based on aggregate information from My MarketBeat watchlists, some other companies that Doximity investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Tesla (TSLA), CrowdStrike (CRWD), PayPal (PYPL) and Invesco QQQ (QQQ). Company Calendar Last Earnings11/09/2021Today12/21/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Custom computer programming services Sub-IndustryComputer Software Current SymbolNASDAQ:DOCS CUSIPN/A CIK1516513 Webwww.doximity.com Phone650-549-4330FaxN/AEmployees890Year FoundedN/APrice Target and Rating Average Stock Price Target$52.59 High Stock Price Target$75.00 Low Stock Price Target$32.00 Potential Upside/Downside-9.1%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage20 Analysts Profitability EPS (Most Recent Fiscal Year)$0.87 Trailing P/E Ratio66.47 Forward P/E Ratio65.72 P/E Growth4.16Net Income$147.58 million Net Margins33.69% Pretax Margin43.79% Return on Equity19.79% Return on Assets16.86% Debt Debt-to-Equity RatioN/A Current Ratio7.24 Quick Ratio7.24 Sales & Book Value Annual Sales$516.85 million Price / Sales20.89 Cash Flow$1.02 per share Price / Cash Flow56.97 Book Value$4.83 per share Price / Book11.97Miscellaneous Outstanding Shares186,692,000Free Float116,869,000Market Cap$10.80 billion OptionableNot Optionable Beta1.40 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report This page (NASDAQ:DOCS) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Doximity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Doximity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.